HX 630
Names
Biological Activity
[Description]:
HX630 is a potent retinoic acid X receptor (RXR) agonist, can induce apoptosis, has anti-tumor effect, and can be used in Cushing's disease research[1].
[Related Catalog]:
[In Vitro]
HX630 (0.1-10 μM, 96 h) 可以剂量依赖性的抑制细胞增殖诱导 AtT20 细胞凋亡[1]。 Cell Viability Assay[1] Cell Line: AtT20 cells Concentration: 0.1, 1, 5, 10 μM Incubation Time: 96 h Result: Significantly inhibited AtT20 cell proliferation at 10 μM. Decreased Pomc mRNA expression and ACTH secretion in a dose-dependent manner.
[In Vivo]
HX630(5 mg/kg,腹腔注射,每周 3 次,持续 3 周)在感染了AtT20 细胞的 BALB/c-nu 小鼠模型中,可以减少肿瘤的生长[1]。 Animal Model: Female BALB/c-nu mice (nu/nu) with AtT20 cells[1] Dosage: 5 mg/kg Administration: i.p., 3 times a week for 3 weeks Result: Significantly reduced tumor volume and Pomc mRNA expression in tumor cells, but body weight and plasma ACTH levels were not significantly different.
[References]
Chemical & Physical Properties
[ Molecular Formula ]:
C28H27NO2S
[ Molecular Weight ]:
441.58
[ Exact Mass ]:
441.17600
[ PSA ]:
74.96000
[ LogP ]:
6.80310
Related Compounds
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.